PCN3 ECONOMIC IMPACT OF SECOND- ANDTHIRD-LINE ERLOTINIB TREATMENT OF NON SMALL-CELL LUNG CANCER-A FRENCH OBSERVATIONAL STUDY

Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65161-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)65161-3/fulltext
Section Title :
Section Order : 319
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65161-3&doi=10.1016/S1098-3015(10)65161-3
HEOR Topics :
Tags :
Regions :